SEC 13F Intelligence

Infinitum Asset Management, LLC / AVBP

Infinitum Asset Management, LLC’s Arrivent Biopharma Inc Position

Does Infinitum Asset Management, LLC own Arrivent Biopharma Inc (AVBP)? Yes — 4.15M shares worth $96M (+11.95% of its 13F portfolio) as of Q1 2026, up from 4.12M shares the prior filed quarter.

Position Value
$96M
Q1 2026
Shares
4.15M
% of Portfolio
+11.95%
Quarters Held
6
currently held

Position History AVBP

Reported value by quarter
Q4 ’24: $44MQ4 ’24Q1 ’25: $38MQ1 ’25Q2 ’25: $74MQ2 ’25Q3 ’25: $71MQ3 ’25Q4 ’25: $83MQ4 ’25Q1 ’26: $96MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20264.15M$96M+11.95%
Q4 20254.12M$83M+12.28%
Q3 20253.87M$71M+13.13%
Q2 20253.42M$74M+16.48%
Q1 20252.07M$38M+12.22%
Q4 20241.64M$44M+23.15%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Infinitum Asset Management, LLC’s full portfolio or all institutional holders of AVBP.